DBV Technologies S.A. - American Depositary Shares — Cash Flow (NASDAQ:DBVT)

Financials

Overview Relatórios Statistics Dividends

Cash from operating activities 165.61 M108.24 M55.67 M79.65 M104.47 M 98.26 M Cash from investing activities 2.87 M433 K100 K808 K757 K -139 K Cash from financing activities 149.55 M274 K194.12 M6.77 M587 K 117.62 M Free cash flow 162.85 M107.32 M54.91 M78.98 M102.14 M 98.23 M

DBV Technologies S.A. - American Depositary Shares

DBV Technologies SA is a publicly owned French biopharmaceutical firm headquartered in Bagneux, France. DBV Technologies is known for developing "Viaskin" technology for administering allergens or antigens to intact skin while avoiding any transfer to the blood. Viaskin Peanut clinical development has received Fast Track designation from the US Food and Drug Administration.